New antigens for a multicomponent blood-stage malaria vaccine
about
Novel approaches to identify protective malaria vaccine candidatesPlasmodium malaria and antimalarial antibodies in the first year of lifeMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaPaths to a malaria vaccine illuminated by parasite genomicsMultiple Plasmodium falciparum Merozoite Surface Protein 1 Complexes Mediate Merozoite Binding to Human ErythrocytesProteomic analysis reveals novel proteins associated with the Plasmodium protein exporter PTEX and a loss of complex stability upon truncation of the core PTEX component, PTEX150P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults.Mining, visualizing and comparing multidimensional biomolecular data using the Genomics Data Miner (GMine) Web-Server.High Sporozoite Antibody Titers in Conjunction with Microscopically Detectable Blood Infection Display Signatures of Protection from Clinical MalariaAn analytical approach to reduce between-plate variation in multiplex assays that measure antibodies to Plasmodium falciparum antigensProtection of Malian children from clinical malaria is associated with recognition of multiple antigens.The Structure of Plasmodium falciparum Blood-Stage 6-Cys Protein Pf41 Reveals an Unexpected Intra-Domain Insertion Required for Pf12 Coordination.A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein InteractionsIn silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection.Genetic Resistance to Malaria Is Associated With Greater Enhancement of Immunoglobulin (Ig)M Than IgG Responses to a Broad Array of Plasmodium falciparum Antigens.Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in KenyaComparative Antibody Responses Against three Antimalarial Vaccine Candidate Antigens from Urban and Rural Exposed Individuals in Gabon.Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.Progress with viral vectored malaria vaccines: A multi-stage approach involving "unnatural immunity".Recent advances in recombinant protein-based malaria vaccines.Vaccine candidate discovery for the next generation of malaria vaccines.Designing malaria vaccines to circumvent antigen variabilityContrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth CohortTargets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.Progress and prospects for blood-stage malaria vaccinesMerozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity.The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.Host-parasite interactions that guide red blood cell invasion by malaria parasites.Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates.Immunity to malaria in an era of declining malaria transmission.The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle.Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.Vaccines to Accelerate Malaria Elimination and Eventual Eradication.Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.Patterns of protective associations differ for antibodies to P.falciparum-infected erythrocytes and merozoites in immunity against malaria in children.Differential T-cell responses to a chimeric Plasmodium falciparum antigen; UB05-09, correlates with acquired immunity to malaria.The structure of Plasmodium falciparum 3D7_0606800 reveals a bi-lobed architecture that supports re-annotation as a Venus Flytrap protein.Functional Analysis Reveals Geographical Variation in Inhibitory Immune Responses Against a Polymorphic Malaria Antigen.
P2860
Q21131082-D8968918-5050-4098-BF64-51EB65208E21Q26315542-1EB3FA5E-86AB-48C0-BCF5-8CDC71F4F58DQ26772878-9562AFCE-305F-4D7E-A1EC-E2821172FB36Q26853267-B779CD83-A5F8-4843-A661-04E9267CBE05Q27972789-6A98B3D1-CA33-43AA-A918-184629C079D4Q27972947-5092A133-63D9-4BCE-A210-ADB2BB631513Q30042821-610DF075-DD32-43F6-BDB5-008A81BBC02CQ30388860-FF8458E7-077D-4296-9853-337B310A7881Q31147151-2FEAA9F1-70A9-4001-8BCC-69220421A674Q33646573-4116DCE6-FEC0-4E7D-AFC2-7907210BE463Q33909630-C98B293A-B101-4D15-83F7-1BFBB398FA9AQ35094826-5D47ECE5-0F7C-47BD-BC47-64B26C660B99Q35790481-9146D938-BC7C-48EA-A4B5-33D5C0AC6E4EQ35877857-E0B4597A-CD38-4013-994A-AE6ED18D2EECQ35898819-BB4302BE-667D-4763-BF77-8A093B7B1A0CQ36018397-10C17063-3102-4CC4-8670-BC0A26A428EBQ36042702-B9EFB3B8-4D43-4A18-AD37-DB644EE62D57Q36148976-97977C50-CE30-4E21-BE2C-13F3CABA81CEQ36226232-E269D79E-A712-4BF5-B1CD-5385EC3DD855Q36381444-D9DE2371-1584-443C-B2C5-218DD6DAAC71Q36394177-10C934D3-790D-4D64-B850-288794D47FAFQ36394182-4D98A78A-2D0F-43A9-9B98-ED8732BB4293Q36413834-7915CAAF-A518-49DB-B20D-9FDFC76DB99AQ36514853-04B72BEC-5525-4988-937C-1D4B8D0698D9Q36555103-C7EE5937-EC46-44DE-A421-50E7EB87382DQ36728063-C280A83E-EC6F-423C-966B-A9637AC4840BQ37025030-F22B205E-0439-4821-9777-4F7B443AFDDEQ37129892-81D332C9-CE41-4770-B549-D8C099F35E7DQ37239883-CA755C07-DB6D-4870-A5AB-B2036AD00D63Q38376500-B9F30012-7AB3-41FF-81F1-C06EF8487D5AQ38672088-41D8B499-199B-4E1B-AEE3-CDE6F308F344Q38689264-98D7F1DE-C924-41DD-B2BA-327BFD16B4ECQ38789240-940198B6-5ABA-4697-86E7-87A148CD3CDEQ39230991-A56FFBFD-5090-45C1-83F1-7AB31300F283Q39296506-4C8292C4-3624-42FD-86F6-D0C3BE9ED4C9Q40055186-0B591C93-CE1F-4D94-B37A-D524C96925D0Q40073901-B5B404F9-8DA7-4B49-A478-F041381FCE49Q40112602-579D8D39-845F-4705-904A-640941C452C8Q40145949-ADE1FDCD-F478-480C-BC88-A9C296AB29A6Q40163275-406FFE6B-F0B5-48F0-B3E4-D8BEE9BE78C4
P2860
New antigens for a multicomponent blood-stage malaria vaccine
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
New antigens for a multicomponent blood-stage malaria vaccine
@ast
New antigens for a multicomponent blood-stage malaria vaccine
@en
type
label
New antigens for a multicomponent blood-stage malaria vaccine
@ast
New antigens for a multicomponent blood-stage malaria vaccine
@en
prefLabel
New antigens for a multicomponent blood-stage malaria vaccine
@ast
New antigens for a multicomponent blood-stage malaria vaccine
@en
P2093
P2860
P50
P1476
New antigens for a multicomponent blood-stage malaria vaccine
@en
P2093
Brian McDade
Cécile Crosnier
Gathoni Kamuyu
Madushi Wanaguru
P2860
P304
P356
10.1126/SCITRANSLMED.3008705
P407
P577
2014-07-01T00:00:00Z